Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Oliver, Stötzer"'
Autor:
Pauline Wimberger, Jens-Uwe Blohmer, Petra Krabisch, Theresa Link, Marianne Just, Bruno Valentin Sinn, Eike Simon, Christine Solbach, Tanja Fehm, Carsten Denkert, Cristin Kühn, Kerstin Rhiem, Hans Tesch, Sherko Kümmel, Andrea Petzold, Oliver Stötzer, Cornelia Meisel, Jan Dominik Kuhlmann, Valentina Nekljudova, Sibylle Loibl
Publikováno v:
Breast Cancer Research, Vol 25, Iss 1, Pp 1-9 (2023)
Abstract Background Disseminated tumor cells (DTCs) in the bone marrow are observed in about 40% at primary diagnosis of breast cancer and predict poor survival. While anti-resorptive therapy with bisphosphonates was shown to eradicate minimal residu
Externí odkaz:
https://doaj.org/article/eb954369b30944128d75b1da2edd9bd4
Autor:
Rolf D. Issels, Lars H. Lindner, Michael von Bergwelt-Baildon, Peter Lang, Christoph Rischpler, Heinz Diem, Barbara Mosetter, Judith Eckl, Dolores J. Schendel, Christoph Salat, Oliver Stötzer, Stefan Burdach, Irene von Luettichau-Teichert, Rupert Handgretinger, Jens Neumann, Thomas Kirchner, Katja Steiger, Melanie Boxberg, Ulrich Mansmann, Gabriele Multhoff, Elfriede Noessner
Publikováno v:
International Journal of Hyperthermia, Vol 37, Iss 1, Pp 55-65 (2020)
Introduction An abscopal effect is a clinical observation whereby a local treatment is associated with regression of metastatic cancer at a site distant from the primary location of treatment. Here, we describe the clinical systemic effect induced by
Externí odkaz:
https://doaj.org/article/994f1713490d468e8ea0a0cafdbdc7df
Autor:
Jens-Uwe, Blohmer, Theresa, Link, Mattea, Reinisch, Marianne, Just, Michael, Untch, Oliver, Stötzer, Peter A, Fasching, Andreas, Schneeweiss, Pauline, Wimberger, Sabine, Seiler, Jens, Huober, Marc, Thill, Christian, Jackisch, Kerstin, Rhiem, Christine, Solbach, Claus, Hanusch, Fenja, Seither, Carsten, Denkert, Knut, Engels, Valentina, Nekljudova, Sibylle, Loibl, John, Hackmann
Publikováno v:
JAMA Oncol
IMPORTANCE: Adjuvant denosumab might improve disease-free survival in hormone receptor (HR)–positive primary breast cancer (BC). The optimal neoadjuvant nab-paclitaxel schedule in terms of efficacy and safety is unclear. OBJECTIVE: To determine whe
Autor:
Toralf Reimer, Wolfgang Janni, Hans Tesch, Kristina Lübbe, Theresa Link, Carsten Denkert, Marianne Just, Jenny Furlanetto, Frederik Marmé, Erich Solomayer, Christian Jackisch, Wolfgang D. Schmitt, Kerstin Rhiem, Mattea Reinisch, Fenja Seither, A Forberger, Peter A. Fasching, Bruno Valentin Sinn, Michael Untch, Sibylle Loibl, Claus Hanusch, Valentina Nekljudova, Christine Solbach, Jens-Uwe Blohmer, Sabine Seiler, Sabine Schmatloch, Andreas Schneeweiss, Elmar Stickeler, Pauline Wimberger, Jens Huober, Marcus Schmidt, Laura Michel, Oliver Stötzer, Eric Hahnen
Publikováno v:
The Lancet Oncology. 22:1151-1161
Summary Background The development of anti-HER2 antibody–drug conjugates opens new therapeutic options for patients with breast cancer, including patients with low expression of HER2. To characterise this new breast cancer subtype, we have compared
Autor:
Peter Bojko, Julia S. Neitz, Oliver Stötzer, Alexander Höllein, Burkhard Schmidt, Sebastian Schulz, Marcus Hentrich, R. Pihusch, Fariborz Abedinpour
Publikováno v:
Acta Oncologica
The COVID-19 pandemic has transformed clinical care around the world with elective procedures being postponed and regular medical care being compromised by patient isolation and repeated testing. D...
Autor:
Stephanie Dille, Richard A. Hansen, Johanna Harde, Karin Potthoff, Oliver Stötzer, Norbert Marschner, Ulrike Söling, Arnd Nusch
Publikováno v:
Clinical Breast Cancer. 20:e315-e326
Background There are only scarce data on treatment of elderly patients with nab-paclitaxel for metastatic breast cancer, especially from the real-world setting. Here we present data from the noninterventional study NABUCCO with special focus on taxan
Autor:
Jens-Uwe Blohmer, Marc Thill, Jens Huober, Oliver Stötzer, Christian Jackisch, Carsten Denkert, Knut Engels, Sibylle Loibl, Theresa Link, Pauline Wimberger, Michael Untch, Peter A. Fasching, Valentina Nekljudova, Marianne Just, Claus Hanusch, Sherko Kümmel, Kerstin Rhiem, Andreas Schneeweiss
Publikováno v:
Cancer Research. 80:GS3-01
Background Pharmacologic inhibition of the receptor RANK with denosumab can prevent or delay bone metastasis in patients with breast cancer (BC) and may improve disease-free survival in postmenopausal woman with hormone receptor (HR) positive BC. The
Autor:
Peter Gibbs, Volker Heinemann, Navesh K. Sharma, Julien Taieb, Jens Ricke, Marc Peeters, Michael Findlay, Bridget Robinson, Christopher Jackson, Andrew Strickland, Val Gebski, Mark Van Buskirk, Huaqing Zhao, Guy van Hazel, Michael Brown, Matthew Burge, Giuseppe Cardaci, Stephen Clarke, Paul Eliadis, Tom Ferguson, Vinod Ganju, Philip James, Chris Karapetis, Winston Liauw, Gavin Marx, Marco Matos, Louise Nott, Nick Pavlakis, Alex Powell, Timothy Price, David Ransom, Eva Segelov, Jenny Shannon, Nimit Singhal, Euan Walpole, Michel Craninx, Thierry Delaunoit, Amélie Deleporte, Michel Ferrante, Karen Geboes, Alain Hendlisz, Koen Hendrickx, Marc De Man, Els Monsaert, Veerle Moons, Marc Polus, Eveline Boucher, Jacques Balosso, Patrick Chevallier, Samy Louafi, Marc Pracht, Christine Rebischung, Denis Smith, Eric Terrebonne, Harald-Robert Bruch, Gerald Gehbauer, Thomas Helmberger, Yon-Dschun Ko, Hendrik Kröning, Frank Lammert, Arnd Nusch, Stefan Pluntke, Karsten Ridwelski, Jorge Riera-Knorrenschild, Hanno Riess, Jorge Ramon Riera, Tilmann Sauerbruch, Klemens Scheidhauer, Oliver Stötzer, Klaus Tatsch, Ursula Vehling-Kaiser, Thomas Vogl, Alex Beny, Ravit Geva, Einat Shacham-Shmueli, Salomon Stemmer, Thomas Tichler, Ido Wolf, Bruna Angelelli, Andrea Martoni, Michael P.N. Findlay, Richard Isaacs, Anne O’Donnell, David Perez, Bridget A. Robinson, Javier Rodríguez, Ruth Vera-Garcia, Pradip Amin, Daniel Bloomgarden, James Bui, James Carlisle, Seungjean Chai, Yi-Jen Chen, Michael Chuong, Andrew Coveler, Francis Facchini, Gary Frenette, Jacob Frick, Michael Garofalo, Benjamin George, Michael Gordon, Seza Gulec, James Hannigan, Matthew Holtzman, Andreas Kaubisch, Adeel Kaiser, Todd Kooy, Steven Limentani, Jeffrey Margolis, Robert Martin, Howard Ozer, Siddarth Padia, William Rilling, Michael Savin, Elyse Schneiderman, Grant Seeger, Navesh Sharma, Stephen Shibata, Randall Smith, Eric Wang, Samuel Whiting, Morteza Aghmesheh, Mathew Burge, Prasad Cooray, Kynan Feeney, Lionel Lim, Madhu Singh, Craig Underhill, Amelie Deleporte, Aurelie Durand, Sandrine Faivre, Aurelie Ferru, Pascal Hammel, Christoph Bremer, Maike De Wit, Hubert Ayala, Norman Heching, Adi Shani, Cristina Granetto, Gianluca Masi, Stefania Mosconi, Gianmauro Numico, Antonio Trogu, Yeul Hong Kim, Han Sae-Won, Chris Jackson, Anne O'Donnell, Maria Fragoso, Iain Tan, Ana Ruiz Casado, Jin Tung Liang, Jin Hwang Liu, Steven Ades, Miklos Auber, Patrick Boland, Charles Bowers, Martin Crain, Kyran Dowling, Renuka Iyer, Lynn Ratner, Federico Sanchez, Patricia Stoltzfus, Mark Westcott
Publikováno v:
Clinical colorectal cancer
The primary tumor side is emerging as a prognostic factor for patients with liver metastatic colorectal cancer (mCRC). In a combined analysis of data from 2 randomized studies, the addition of selective internal radiation therapy to first-line chemot
Autor:
Mareike Darsow, Susanne Classen, Annette Lebeau, Reinhold Munker, Wolfgang Wilmanns, Oliver Stötzer
Publikováno v:
Cancer immunology, immunotherapy : CII. 42(3)
Mutated human p53 may give rise to the formation of autoantibodies and may be a marker for a worse prognosis. We speculated that ascites or pleural effusions may enhance the formation of such autoantibodies in cancer patients and, therefore, we measu